Evidence map›Paper›PMID 38013742›Full record

ArticleInfectious medicine2023

Hesitant adopters: COVID-19 vaccine hesitancy among diverse vaccinated adults in the United States.

Sharon Reece, Sheena CarlLee, Aaron J Scott, Don E Willis, Brett Rowland, Kristin Larsen, Ijanae Holman-Allgood, Pearl A McElfish

Open access · goldFull text read
In one paragraph

Article in Infectious medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Sociodemographic factors associated with vaccine hesitancy in the South Asian community in Canada.Canadian journal of public health = Revue canadienne de sante publique · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sharon ReeceCollege of Medicine, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR 72703, USA.
Sheena CarlLeeCollege of Medicine, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR 72703, USA.
Aaron J ScottOffice of Community Health and Research, University of Arkansas for Medical Sciences Northwest, Springdale, AR 72703, USA.
Don E WillisCollege of Medicine, University of Arkansas for Medical Sciences Northwest, Springdale, AR 72703, USA.
Brett RowlandOffice of Community Health and Research, University of Arkansas for Medical Sciences Northwest, Springdale, AR 72703, USA.
Kristin LarsenCollege of Medicine, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR 72703, USA.
Ijanae Holman-AllgoodCollege of Medicine, University of Arkansas for Medical Sciences Northwest, Fayetteville, AR 72703, USA.
Pearl A McElfishCollege of Medicine, University of Arkansas for Medical Sciences Northwest, Springdale, AR 72703, USA.
University of Arkansas for Medical Sciences · US

Funding

Evaluation of the cognitive function and socioeconomic, biomedical, and genetic risk factors of Alzheimer’s disease and related dementias (ADRD) in older Marshallese residents of Northwest ArkansasR01MD013852 · NIMHD · UNIV OF ARKANSAS FOR MED SCIS · PI MCELFISH, PEARL · 2019 to 2023
$7.2M
NIMHD NIH HHS R01 MD013852
6 · The paper itself

Abstract

Background: Despite the United States (US) having an abundant supply of COVID-19 vaccines, vaccination rates lag behind other high-income countries, suggesting that vaccine hesitancy and attitudes play a greater role in public health measures than pure supply and access. With the acknowledgment that vaccination attitudes and status may or may not be correlated, this study examined COVID-19 vaccine hesitancy among vaccinated US adults by asking: 1) What is the prevalence of COVID-19 vaccine hesitancy among the vaccinated? 2) Does COVID-19 vaccine hesitancy vary across sociodemographic characteristics? 3) Does COVID-19 vaccine hesitancy vary by healthcare access and influenza vaccination over the past 5 years? Methods: Data were collected through an online survey of 2022 US adults with a final analytic sample of 1383 vaccinated respondents. Results: Overall, 48.8% of vaccinated adults reported some level of hesitancy, while a slight majority reported they were "not at all hesitant". Younger respondents, women, and Black and American Indian or Alaska Native participants had greater adjusted odds of being more hesitant towards receiving the COVID-19 vaccine. Respondents who had a primary care physician had greater adjusted odds than those who did not have a primary care physician of being more hesitant towards receiving the COVID-19 vaccine. Conclusions: This is the first population-based national sample study examining COVID-19 vaccine hesitancy among vaccinated individuals from subgroups of distinctive backgrounds in order to inform targeted strategies for reducing vaccine hesitancy. Findings can assist in efforts to increase vaccination rates and also decrease vaccine hesitancy at the national level.

Indexed as

COVID-19 vaccineHesitant adoptersUS adultsVaccine hesitancy

Identifiers

PMID38013742
PMCPMC10038887
OpenAlexW4360954554

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read24
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.